Glaxosmithkline
🚨 Critical Risk
FEI: 3003451948 • Brentford, Middlesex • UNITED KINGDOM
FEI Number
3003451948
Location
Brentford, Middlesex
Country
UNITED KINGDOMAddress
G S K House, 980 Great West Road, Brentford, Middlesex, United Kingdom
Critical Risk
FDA Import Risk Assessment
This firm has an extensive history of FDA import refusals with severe violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNSAFE COL
The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).
COLOR LBLG
The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
HEALTH C
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
TRANSFAT
The product is misbranded under Section 403(q) because the nutrition label does not provide all of the information required by 21 CFR 101.9(c); specifically, the label does not bear the amount of trans fat [21 CFR 101.9(c)(2)(ii)].
COL ADDED
The article appears to bear or contain, for the purpose of coloring only, a color additive which is unsafe within the meaning of Section 721(a).
NO PROCESS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the manufacturer's failure to file a scheduled process demonstrates that the product is not being manufactured under the mandatory provisions of 21 CFR Part 108 and therefore appears to have been manufactured, processed, or packed, under insanitary conditions whereby it may have been rendered injurious to health.
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
LACKS N/C
The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.
NEEDS FCE
It appears the manufacturer is not registered as a low acid canned food or acidified food manufacturer pursuant to 21 CFR 108.25(c)(1) or 108.35(c)(1).
FLAVR LBLG
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain an artificial flavoring and it fails to bear labeling stating that fact.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
WARNINGS
It appears to lack adequate warning against use in a pathological condition or by children where it may be dangerous to health or against an unsafe dose, method, administering duration, application, in manner/form, to protect users.
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
UNSAFE ADD
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
UNSAFE COL
The article appears to be a color additive for the purposes of coloring only in or on drugs or devices, and is unsafe within the meaning of Section 721(a).
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/24/2025 | 61MDA38LAMOTRIGINE (ANTI-CONVULSANT) | Division of Northeast Imports (DNEI) | |
| 7/18/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/18/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/27/2025 | 63BCQ25FLUTICASONE PROPIONATE (BRONCHODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/2/2024 | 54AGA05VITAMIN B12 (CYANOCOBALAMIN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/2/2024 | 66EDA99IODINE SUPPLEMENT N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/2/2024 | 62FDA99ANTI-INFECTIVE, TOPICAL N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/1/2024 | 56YDA99ANTIBIOTIC N.E.C. | Division of Northern Border Imports (DNBI) | |
| 4/1/2024 | 63BCL01ALBUTEROL (BRONCHODILATOR) | Division of Northern Border Imports (DNBI) | |
| 1/11/2024 | 53IG01DENTIFRICES (AEROSOL, LIQUID, TOOTHPASTES, TOOTHPOWDERS), WITHOUT FLUORIDE (ORAL HYGIENE PRODUCTS) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/14/2023 | 76EFTCLEANSER, DENTURE, OTC | Division of Southeast Imports (DSEI) | |
| 11/8/2023 | 63OCY07SUMATRIPTAN SUCCINATE (ANTIMIGRAINE AGENT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/24/2023 | 63RBY04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC) | Division of Northeast Imports (DNEI) | |
| 4/5/2023 | 61NCF05BUPROPION HCL (ANTI-DEPRESSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/29/2022 | 60ZDL02ALBENDAZOLE (ANTIPARASITIC) | Division of Southeast Imports (DSEI) | |
| 6/13/2022 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/19/2020 | 66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/19/2020 | 66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/27/2020 | 62VDJ99ANTI-VIRAL N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2020 | 63BCY01ALBUTEROL (BRONCHODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/6/2020 | 64UDY08DUTASTERIDE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/13/2020 | 63BDQ01ALBUTEROL (BRONCHODILATOR) | Division of Northern Border Imports (DNBI) | |
| 3/13/2020 | 63BDQ99BRONCHODILATOR N.E.C. | Division of Northern Border Imports (DNBI) | |
| 3/13/2019 | 62GBY18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 10/5/2018 | 62GAY41IBUPROFEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/3/2018 | 56BCA03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2017 | 61XCY50AZELASTINE HYDROCHLORIDE/FLUTICASONE, ANTI-HISTAMINE STEROID (ANTI-HISTAMINIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2017 | 61XCY50AZELASTINE HYDROCHLORIDE/FLUTICASONE, ANTI-HISTAMINE STEROID (ANTI-HISTAMINIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/21/2017 | 61EAY99ANTI-ASTHMATIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/28/2016 | 66BBQ44NICOTINE DELIVERY SYSTEM | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 10/13/2016 | 63BCQ01ALBUTEROL (BRONCHODILATOR) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 10/5/2016 | 02JHT99MALT PRODUCTS, N.E.C. | Division of Southwest Imports (DSWI) | |
| 9/13/2016 | 62VBO18ACYCLOVIR (ANTI-VIRAL) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/5/2016 | 63RDL99DENTAL CARIES PROPHYLACTIC N.E.C. | Division of Northeast Imports (DNEI) | |
| 3/2/2016 | 56BCL03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 3/16/2015 | 63BDQ25FLUTICASONE PROPIONATE (BRONCHODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/11/2015 | 62WBY99ASTRINGENT/ANTI-PERSPIRANT N.E.C. | Cincinnati District Office (CIN-DO) | |
| 9/30/2014 | 66BBY44NICOTINE DELIVERY SYSTEM | Division of Northeast Imports (DNEI) | |
| 5/22/2014 | 60RAH18ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC) | 75UNAPPROVED | Philadelphia District Office (PHI-DO) |
| 9/4/2012 | 30JFY02BEVERAGE BASE, IMITATION CITRUS | Southwest Import District Office (SWI-DO) | |
| 12/28/2011 | 66VIP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/27/2011 | 66VIP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/13/2011 | 56EBO65OXYTETRACYCLINE (TETRACYCLINES) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 11/2/2011 | 63XAA26HISTAMINE PHOSPHATE (DIAGNOSTIC AID) (DRUGS) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/23/2011 | 62LDA44ATOVAQUONE (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/15/2011 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 3/15/2011 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 2/24/2011 | 29BCT99CARBONATED SOFT DRINK, N.E.C. | 11UNSAFE COL | New York District Office (NYK-DO) |
| 1/6/2011 | 60LBA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2011 | 60LBA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/3/2010 | 60LCA88SUMATRIPTAN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/3/2010 | 60LCA88SUMATRIPTAN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/3/2010 | 60LCQ88SUMATRIPTAN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 9/17/2010 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 9/17/2010 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | 218LIST INGRE | Los Angeles District Office (LOS-DO) |
| 9/17/2010 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | 218LIST INGRE | Los Angeles District Office (LOS-DO) |
| 7/29/2010 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 7/29/2010 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 7/26/2010 | 61ECA11SALMETEROL XINAFOATE (ANTI-ASTHMATIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 5/11/2010 | 66BCY44NICOTINE DELIVERY SYSTEM | 75UNAPPROVED | New York District Office (NYK-DO) |
| 11/10/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 11/10/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 11/10/2009 | 29BCT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 11/3/2009 | 61XBB08CHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC) | Detroit District Office (DET-DO) | |
| 10/26/2009 | 29AGT01SOFT DRINK, BERRY FRUIT FLAVORED, NONCARBONATED | Los Angeles District Office (LOS-DO) | |
| 10/26/2009 | 29AGT01SOFT DRINK, BERRY FRUIT FLAVORED, NONCARBONATED | 11UNSAFE COL | Los Angeles District Office (LOS-DO) |
| 10/26/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | 11UNSAFE COL | Los Angeles District Office (LOS-DO) |
| 10/22/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | 11UNSAFE COL | Los Angeles District Office (LOS-DO) |
| 10/2/2009 | 29BHT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 10/1/2009 | 29AGT01SOFT DRINK, BERRY FRUIT FLAVORED, NONCARBONATED | Los Angeles District Office (LOS-DO) | |
| 10/1/2009 | 29AGT01SOFT DRINK, BERRY FRUIT FLAVORED, NONCARBONATED | Los Angeles District Office (LOS-DO) | |
| 9/30/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 9/30/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 9/30/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 9/30/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 9/17/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 8/26/2009 | 60LDL01ACETAMINOPHEN (ANALGESIC) | New Orleans District Office (NOL-DO) | |
| 8/26/2009 | 61TDL17PROMETHAZINE HCL (ANTI-EMETIC/NAUSEANT) | New Orleans District Office (NOL-DO) | |
| 8/25/2009 | 66VIP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 7/30/2009 | 64LAO67CLOBETASOL PROPIONATE (GLUCOCORTICOID) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 7/14/2009 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 6/30/2009 | 63RBY04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC) | Baltimore District Office (BLT-DO) | |
| 1/9/2009 | 64LDO67CLOBETASOL PROPIONATE (GLUCOCORTICOID) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/9/2008 | 27YCE03CHUTNEY | Los Angeles District Office (LOS-DO) | |
| 12/9/2008 | 29BHE99CARBONATED SOFT DRINK, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 12/9/2008 | 29AET99NONCARBONATED SOFT DRINK, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 9/3/2008 | 61NDP76PAROXETINE (ANTI-DEPRESSANT) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 8/8/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 8/5/2008 | 29BET99CARBONATED SOFT DRINK, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 8/5/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 8/5/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 8/5/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 6/9/2008 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 6/9/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 5/21/2008 | 29BHT99CARBONATED SOFT DRINK, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 5/21/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 5/21/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) | |
| 5/12/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | 482NUTRIT LBL | Los Angeles District Office (LOS-DO) |
| 5/12/2008 | 29AGT01SOFT DRINK, BERRY FRUIT FLAVORED, NONCARBONATED | Los Angeles District Office (LOS-DO) | |
| 5/12/2008 | 29BGT02SOFT DRINK, CITRUS FRUIT FLAVORED, CARBONATED | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is Glaxosmithkline's FDA import refusal history?
Glaxosmithkline (FEI: 3003451948) has 190 FDA import refusal record(s) in our database, spanning from 5/1/2003 to 10/24/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxosmithkline's FEI number is 3003451948.
What types of violations has Glaxosmithkline received?
Glaxosmithkline has been cited for 27 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Glaxosmithkline come from?
All FDA import refusal data for Glaxosmithkline is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.